Literature DB >> 8580021

Effect of rifampin on Staphylococcus aureus colonization in children on chronic peritoneal dialysis.

C D Hanevold1, M C Fisher, R Waltz, S Bartosh, H J Baluarte.   

Abstract

The efficacy of rifampin in eliminating Staphylococcus aureus colonization was evaluated in a pediatric peritoneal dialysis population. Six children with documented nasal colonization were treated for 7 days with rifampin and cloxacillin. Although antimicrobial therapy eliminated nasal carriage in all patients, recolonization occurred in 66%. Exit site colonization proved difficult to eradicate with negative cultures documented in only 3 of 5 children after rifampin/cloxacillin therapy. Although S. aureus carriage is a risk factor for S. aureus infections, efforts to eradicate carriage with rifampin are hindered by rapid recolonization.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8580021     DOI: 10.1007/bf00860952

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  13 in total

1.  Adult and pediatric peritonitis rates in a home dialysis program: comparison of continuous ambulatory and continuous cycling peritoneal dialysis.

Authors:  R L Howard; J Millspaugh; I Teitelbaum
Journal:  Am J Kidney Dis       Date:  1990-11       Impact factor: 8.860

2.  Effect of rifampin on nasal carriage of Staphylococcus aureus.

Authors:  M A Sande; G L Mandell
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

3.  Long-term studies of the effect of rifampin on nasal carriage of coagulase-positive staphylococci.

Authors:  L J Wheat; R B Kohler; F C Luft; A White
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

4.  Staphylococcus aureus skin carriage and development of peritonitis in patients on continuous ambulatory peritoneal dialysis.

Authors:  R Sesso; S Draibe; A Castelo; I Sato; I Leme; D Barbosa; O Ramos
Journal:  Clin Nephrol       Date:  1989-05       Impact factor: 0.975

5.  Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.

Authors:  A Pignatari; M Pfaller; R Hollis; R Sesso; I Leme; L Herwaldt
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

Review 6.  Skin and skin structure infections in the patient at risk: carrier state of Staphylococcus aureus.

Authors:  C U Tuazon
Journal:  Am J Med       Date:  1984-05-15       Impact factor: 4.965

7.  Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis.

Authors:  V L Yu; A Goetz; M Wagener; P B Smith; J D Rihs; J Hanchett; J J Zuravleff
Journal:  N Engl J Med       Date:  1986-07-10       Impact factor: 91.245

8.  Staphylococcus aureus peritonitis is associated with Staphylococcus aureus nasal carriage in peritoneal dialysis patients.

Authors:  B Piraino; J A Perlmutter; J L Holley; J Bernardini
Journal:  Perit Dial Int       Date:  1993       Impact factor: 1.756

9.  Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections.

Authors:  S W Zimmerman; E Ahrens; C A Johnson; W Craig; J Leggett; M O'Brien; L Oxton; E B Roecker; S Engeseth
Journal:  Am J Kidney Dis       Date:  1991-08       Impact factor: 8.860

10.  Maintenance dialysis in North American children and adolescents: a preliminary report. North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

Authors:  S R Alexander; E K Sullivan; W E Harmon; D M Stablein; A Tejani
Journal:  Kidney Int Suppl       Date:  1993-10       Impact factor: 10.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.